Rankings
▼
Calendar
ALKS Q1 2019 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$223M
-0.9% YoY
Gross Profit
$178M
79.7% margin
Operating Income
-$76M
-34.1% margin
Net Income
-$96M
-43.2% margin
EPS (Diluted)
$-0.62
QoQ Revenue Growth
-29.3%
Cash Flow
Operating Cash Flow
$22M
Free Cash Flow
-$1M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$654M
Stockholders' Equity
$1.1B
Cash & Equivalents
$225M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$223M
$225M
-0.9%
Gross Profit
$178M
$181M
-1.6%
Operating Income
-$76M
-$62M
-22.8%
Net Income
-$96M
-$63M
-54.2%
Revenue Segments
Manufactured Product And Royalty
$109M
49%
Product
$99M
45%
Research And Development
$15M
7%
← FY 2019
All Quarters
Q2 2019 →